Novo Nordisk A/S
DUS:NOVA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
N
|
Novo Nordisk A/S
DUS:NOVA
|
DK |
|
C
|
CKX Lands Inc
AMEX:CKX
|
US |
|
S
|
Sany Heavy Equipment International Holdings Company Ltd
XMUN:YXS
|
CN |
|
G
|
GeoPark Ltd
LSE:0MDP
|
CO |
|
L
|
Lonza Group AG
XMUN:LO3
|
CH |
|
A
|
Adobe Inc
SWB:ADB
|
US |
|
S
|
Supernus Pharmaceuticals Inc
F:S49
|
US |
Wall St Price Targets
NOVA Price Targets Summary
Novo Nordisk A/S
According to Wall Street analysts, the average 1-year price target for NOVA is 41.63 EUR with a low forecast of 22.96 EUR and a high forecast of 60.57 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is NOVA's stock price target?
Price Target
41.63
EUR
According to Wall Street analysts, the average 1-year price target for NOVA is 41.63 EUR with a low forecast of 22.96 EUR and a high forecast of 60.57 EUR.
What is the Revenue forecast for Novo Nordisk A/S?
Projected CAGR
2%
Over the last 14 years, the compound annual growth rate for Revenue has been 12%. The projected CAGR for the next 8 years is 2%.
What is the Operating Income forecast for Novo Nordisk A/S?
Projected CAGR
-3%
Over the last 14 years, the compound annual growth rate for Operating Income has been 13%. The projected CAGR for the next 8 years is -3%.
What is the Net Income forecast for Novo Nordisk A/S?
Projected CAGR
-1%
Over the last 14 years, the compound annual growth rate for Net Income has been 14%. The projected CAGR for the next 8 years is -1%.
